title: Part One: For the motion. All TEVAR patients must be followed lifelong by annual CTA/MRA. [Pro].
authors.affiliation: Department of Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: S
authors.initials: S
authors.lastname: Wong
authors.forename: T M
authors.initials: TM
authors.lastname: Mastracci
mesh_terms: D000367:Age Factors; D001013:Aorta, Thoracic / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D001018:Aortic Diseases / Q000601:surgery*; D001027:Aortography / Q000379:methods*; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation; D003952:Diagnostic Imaging / Q000379:methods*; D057867:Endoleak / Q000175:diagnosis / Q000209:etiology; D057510:Endovascular Procedures / Q000009:adverse effects* / Q000295:instrumentation; D005548:Foreign-Body Migration / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D018810:Magnetic Resonance Angiography; D011159:Population Surveillance; D011237:Predictive Value of Tests; D011475:Prosthesis Failure; D015607:Stents; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome